Prostate Cancer
Sociodemographic disparities in prostate cancer imaging.
September 27, 2024
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
September 27, 2024
The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer.
September 27, 2024
Utility of dynamic contrast enhancement for clinically significant prostate cancer detection.
September 27, 2024
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants.
September 27, 2024
Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Indication for NUBEQA® (darolutamide) in Metastatic Hormone-Sensitive Prostate Cancer
September 26, 2024
A Case of Rapidly Progressive De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer.
September 26, 2024
Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival.
September 26, 2024
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?
September 25, 2024
Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free Interval.
September 25, 2024
Integrating PARP Inhibitors in mCRPC Therapy: Current Strategies and Emerging Trends.
September 24, 2024